Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025
SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
Bombay High Court Dismisses PIL Filed Against Apex Insurance Consultant Ltd., Restores Confidence in Medical Community
NEW DELHI and MUMBAI, India, June 19, 2025 /PRNewswire/ -- The Bombay High…
Asia Tech x Singapore 2025 Recap
SINGAPORE, June 10, 2025 /PRNewswire/ -- At the recent ATxSummit, the apex event…